Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens
Hematology, Oncology and Stem Cell Therapy. 2017; 10 (1): 15-21
en Inglés
| IMEMR
| ID: emr-186591
ABSTRACT
Objective / background:
A decision about the need for antimicrobial therapy in a patient with febrile neutropenia after hematopoietic stem cell transplantation [HSCT] is often complicated because of the low frequency of culture isolation and reduced clinical manifestation of infection. Usefulness and choice of sepsis biomarkers to distinguish bloodstream infection [BSI] from other causes of febrile episode is still argued in HSCT recipients in modern epidemiological situations characterized by the emergence of highly resistant gram-negative microorganisms. In this study a comparative analysis of diagnostic values of presepsin, procalcitonin [PCT], and C-reactive protein [CRP] was performed as sepsis biomarkers in adult patients after HSCT in a condition of high prevalence of gram-negative pathogens
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Estudio de prevalencia
Idioma:
Inglés
Revista:
Hematol. Oncol. Stem Cell Ther.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS